Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells

Cancer Biology and Therapy

Volumn 6, Issue 9, 2007, Pages 1433-1437

  Kumar, K G Suresh ^a   Liu, Jianghuai ^a   Li, Ying ^a   Yu, Duonan ^a   Thomas Tikhonenko, Andrei ^a   Herlyn, Meenhard ^b   Fuchs, Serge Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

BAY 43 9006; BRAF; Interferon ; Melanoma; Raf inhibitor; Ubiquitin; Trcp

Indexed keywords

ALPHA INTERFERON; B RAF KINASE; INTERFERON RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; RAF PROTEIN; SORAFENIB; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MELANOMA CELL;

EID: 42549166042     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.9.4569     Document Type: Article

References (32)